A review of drug-induced hypernatraemia

NDT Plus

Volumn 2, Issue 5, 2009, Pages 339-346

  Liamis, George ^a   Milionis, Haralampos J ^a   Elisaf, Moses ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

adverse drug reaction; diabetes insipidus; hypernatraemia; sodium homeostasis

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; AMILORIDE; AMINOGLYCOSIDE; AMPHOTERICIN; AMPHOTERICIN B; BICARBONATE; CISPLATIN; COLCHICINE; DEMECLOCYCLINE; DIURETIC AGENT; ENEMA; FOSCARNET; HYPERTONIC SOLUTION; LACTULOSE; LITHIUM; MANNITOL; PENICILLIN DERIVATIVE; PHENYTOIN; RETINOL; SODIUM; SODIUM CHLORIDE; SORBITOL; THIAZIDE DIURETIC AGENT; VASOPRESSIN ANTAGONIST; VINBLASTINE; VITAMIN D;

DIALYSIS; DIET SUPPLEMENTATION; DRUG INDUCED DISEASE; DRUG INDUCED HYPERNATREMIA; DRUG WITHDRAWAL; HUMAN; HYPERNATREMIA; INCIDENCE; INTESTINE LAVAGE; INTRAVENOUS FEEDING; NEPHROGENIC DIABETES INSIPIDUS; OSMORECEPTOR; OSMOREGULATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SODIUM BLOOD LEVEL; SODIUM RESTRICTION; WATER LOSS;

EID: 77956053492     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfp085     Document Type: Review

References (85)

1. Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med 1996; 124: 197-203
2. Aiyagari V, Deibert E, DiringerMN. Hypernatremia in the neurologic intensive care unit: how high is too high? J Crit Care 2006; 21: 163-172
3. Polderman KH, Schreuder WO, Strack van Schijndel RJ et al. Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med 1999; 27: 1105-1108
4. Robertson GL. Physiology of ADH secretion. Kidney Int Suppl 1987; 21: S20-S26
5. Robertson GL. Abnormalities of thirst regulation. Kidney Int 1984; 25: 460-469
6. Moritz ML, Ayus JC. The changing pattern of hypernatremia in hospitalized children. Pediatrics 1999; 104: 435-439
7. Edelman IS, Leibman J, O'Meara MP et al. Interrelations between serumsodium concentration, serumosmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 1958; 37: 1236-1256
8. Gennari FJ, Kassirer JP. Osmotic diuresis. N Engl J Med 1974; 291: 714-720
9. Milionis HJ, Liamis G, Elisaf MS. Hypernatremia in hospitalized patients: a sequel of inadvertent fluid administration. Arch InternMed 2000; 160: 1541-1542
10. Milionis HJ, Liamis G, Elisaf MS. Appropriate treatment of hypernatraemia in diabetic hyperglycaemic hyperosmolar syndrome. J Intern Med 2001; 249: 273-276
11. Marples D, Frokiaer J, Knepper MA et al. Disordered water channel expression and distribution in acquired nephrogenic diabetes insipidus. Proc Assoc Am Physicians 1998; 110: 401-406
12. Verbalis JG. Diabetes insipidus. Rev Endocr Metab Disord 2003; 4: 177-185
13. Sands JM, Bichet DG. Nephrogenic diabetes insipidus. Ann Intern Med 2006; 144: 186-194
14. Khanna A. Acquired nephrogenic diabetes insipidus. Semin Nephrol 2006; 26: 244-248
15. Amlal H, Krane CM, Chen Q et al. Early polyuria and urinary concentrating defect in potassium deprivation. Am J Physiol Renal Physiol 2000; 279: F655-F663
16. Nguyen MK, Nielsen S, Kurtz I. Molecular pathogenesis of nephrogenic diabetes insipidus. Clin Exp Nephrol 2003; 7: 9-17
17. Levi M, Peterson L, Berl T.Mechanism of concentrating defect in hypercalcemia. Role of polydipsia and prostaglandins. Kidney Int 1983; 23: 489-497
18. Jeffery J, Ayling RM, McGonigle RJ. Successful rescue of severe hypernatraemia (196 mmol/L) by treatment with hypotonic fluid. Ann Clin Biochem 2007; 44: 491-494
19. Timmer RT, Sands JM. Lithium intoxication. J Am Soc Nephrol 1999; 10: 666-674
20. Hansen HE, Amdisen A. Lithium intoxication. Report of 23 cases and review of 100 cases from the literature. Q J Med 1978; 47: 123-144
21. Cogan E, Svoboda M, Abramow M. Mechanisms of lithiumvasopressin interaction in rabbit cortical collecting tubule. Am J Physiol 1987; 252: F1080-F1087
22. Li Y, Shaw S, Kamsteeg EJ et al. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity. J Am Soc Nephrol 2006; 17: 1063-1072
23. DeWardener HE, Herxheimer A. The effect of a high water intake on the kidney's ability to concentrate the urine in man. 1957. J Am Soc Nephrol 2000; 11: 980-987
24. Salata R, Klein I. Effects of lithium on the endocrine system: a review. J Lab Clin Med 1987; 110: 130-136
25. Miller PD, Linas SL, Schrier RW. Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. JAMA 1980; 243: 2513-2515
26. Forrest JN Jr, Cox M, Hong C et al. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1978; 298: 173-177
27. Ullmann AJ. Nephrotoxicity in the setting of invasive fungal diseases. Mycoses 2008; 51(Suppl 1): 25-30
28. Kim SW, Yeum CH, Kim S et al. Amphotericin B decreases adenylyl cyclase activity and aquaporin-2 expression in rat kidney. J Lab Clin Med 2001; 138: 243-249
29. Barbour GL, Straub KD, O'Neal BL et al. Vasopressin-resistant nephrogenic diabetes insipidus. A result of amphotericin B therapy. Arch Intern Med 1979; 139: 86-88
30. Smith OP, Gale R, Hamon M et al. Amphotericin B-induced nephrogenic diabetes insipidus: resolution with its liposomal counterpart. Bone Marrow Transplant 1994; 13: 107-108
31. Spath-Schwalbe E, Koschuth A, Dietzmann A et al. Successful use of liposomal amphotericin B in a case of amphotericin B-induced nephrogenic diabetes insipidus. Clin Infect Dis 1999; 28: 680-681
32. Canada TW,Weavind LM, Augustin KM. Possible liposomal amphotericin B-induced nephrogenic diabetes insipidus. Ann Pharmacother 2003; 37: 70-73
33. Mills W, Chopra R, Linch DC et al. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Br J Haematol 1994; 86: 754-760
34. Garofeanu CG,Weir M, Rosas-ArellanoMP et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis 2005; 45: 626-637
35. Navarro JF, Quereda C, Gallego N et al. Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy. Am J Kidney Dis 1996; 27: 431-434
36. Usalan C, Altun B, Ulusoy S et al. Hypernatraemia and polyuria due to high-dose colchicine in a suicidal patient. Nephrol Dial Transplant 1999; 14: 1556-1557
37. Konstam MA, Gheorghiade M, Burnett JC Jr et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007; 297: 1319-1331
38. Schrier RW, Gross P, GheorghiadeMet al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006; 355: 2099-2112
39. Gheorghiade M, Niazi I, Ouyang J et al. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial. Circulation 2003; 107: 2690-2696
40. Decaux G, Soupart A, Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 2008; 371: 1624-1632
41. Luscher TF, Siegenthaler-Zuber G, Kuhlmann U. Severe hypernatremic coma due to diphenylhydantoin intoxication. Clin Nephrol 1983; 20: 268-269
42. Sordillo P, Sagransky DM, Mercado RM et al. Carbamazepineinduced syndrome of inappropriate antidiuretic hormone secretion. Reversal by concomitant phenytoin therapy. Arch Intern Med 1978; 138: 299-301
43. Perucca E, Richens A. Reversal by phenytoin of carbamazepineinduced water intoxication: a pharmacokinetic interaction. J Neurol Neurosurg Psychiatry 1980; 43: 540-545
44. Elisaf M, Merkouropoulos M, Tsianos EV et al. Acid-base and electrolyte abnormalities in alcoholic patients. Miner Electrolyte Metab 1994; 20: 274-281
45. Lamminpaa A, Vilska J. Acid-base balance in alcohol users seen in an emergency room. Vet Hum Toxicol 1991; 33: 482-485
46. Rauchenzauner M, Kountchev J, Ulmer H et al. Disturbances of electrolytes and blood chemistry in acute alcohol intoxication. Wien Klin Wochenschr 2005; 117: 83-91
47. Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med 1986; 81: 1033-1040
48. de Luis DA, Aller R, Izaola O et al. Experience of 6 years with home enteral nutrition in an area of Spain. Eur J Clin Nutr 2006; 60: 553-557
49. Vanlandingham S, Simpson S, Daniel P et al.Metabolic abnormalities in patients supported with enteral tube feeding. JPEN J Parenter Enteral Nutr 1981; 5: 322-324
50. Liamis G, Kalaitzidis R, Elisaf M. Hypernatremia during correction of hypercalcemia. Nephron 2000; 86: 358
51. Liamis G, Tsimihodimos V, Doumas M et al. Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinic. Nephrol Dial Transplant 2008; 23: 136-143
52. Snyder NA, Feigal DW, Arieff AI. Hypernatremia in elderly patients. A heterogeneous,morbid, and iatrogenic entity. Ann InternMed 1987; 107: 309-319
53. Decaux G, Unger J, Mockel J. Urea therapy for inappropriate antidiuretic hormone secretion from tuberculous meningitis. JAMA 1980; 244: 589-590
54. Decaux G. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by long loop diuretics. Nephron 1983; 35: 82-88
55. Hoorn EJ, Betjes MG,Weigel J, Zietse R. Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transplant 2008; 23: 1562-1568
56. Allerton JP, Strom JA. Hypernatremia due to repeated doses of charcoal-sorbitol. Am J Kidney Dis 1991; 17: 581-584
57. Nanji AA, Lauener RW. Lactulose-induced hypernatremia. Drug Intell Clin Pharm 1984; 18: 70-71
58. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342: 1493-1499
59. Elisaf M, Litou H, Siamopoulos KC. Survival after severe iatrogenic hypernatremia. Am J Kidney Dis 1989; 14: 230-231
60. Mirchandani HG, Mirchandani IH, Parikh SR. Hypernatremia due to amniotic fluid embolism during a saline-induced abortion. Am J Forensic Med Pathol 1988; 9: 48-50
61. Reid DE, Frigoletto FD Jr, Goodlin RC. Hypernatremia from intravascular saline infusion during therapeutic abortion. JAMA 1972; 220: 1749
62. Mattar JA, Weil MH, Shubin H et al. Cardiac arrest in the critically ill: II. Hyperosmolal states following cardiac arrest. Am J Med 1974; 56: 162-168
63. Webb AK, Phillips MJ, Hanson GC. Iatrogenic nondiabetic hyperosmolar states. J R Soc Med 1979; 72: 578-586
64. Albi A, Baudin F, Matmar M et al. Severe hypernatremia after hypertonic saline irrigation of hydatid cysts. Anesth Analg 2002; 95: 1806-1808, table of contents
65. Krige JE, Millar AJ, Rode H et al. Fatal hypernatraemia after hypertonic saline irrigation of hepatic hydatid cysts. Pediatr Surg Int 2002; 18: 64-65
66. Meadow R. Non-accidental salt poisoning. Arch Dis Child 1993; 68: 448-452
67. Sotos JF, Cutler EA, Finkel MA et al. Hypocalcemic coma following two pediatric phosphate enemas. Pediatrics 1977; 60: 305-307
68. Aradhye S, Brensilver JM. Sodium phosphate-induced hypernatremia in an elderly patient: a complex pathophysiologic state. Am J Kidney Dis 1991; 18: 609-611
69. Martin RR, Lisehora GR, Braxton M Jr et al. Fatal poisoning from sodium phosphate enema. Case report and experimental study. JAMA 1987; 257: 2190-2192
70. Langer JC, Paes BM, Gray S. Hypernatremia associated with Nacetylcysteine therapy for meconium ileus in a premature infant. CMAJ 1990; 143: 202-203
71. Moder KG, Hurley DL. Fatal hypernatremia from exogenous salt intake: report of a case and review of the literature. Mayo Clin Proc 1990; 65: 1587-1594
72. Turk EE, Schulz F, Koops E et al. Fatal hypernatremia after using salt as an emetic-report of three autopsy cases. Leg Med (Tokyo) 2005; 7: 47-50
73. Ofran Y, Lavi D, Opher D et al. Fatal voluntary salt intake resulting in the highest ever documented sodium plasma level in adults (255 mmol L-1): a disorder linked to female gender and psychiatric disorders. J Intern Med 2004; 256: 525-528
74. Himmelstein DU, Jones AA,Woolhandler S. Hypernatremic dehydration in nursing home patients: an indicator of neglect. J Am Geriatr Soc 1983; 31: 466-471
75. Macaulay D,Watson M. Hypernatraemia in infants as a cause of brain damage. Arch Dis Child 1967; 42: 485-491
76. Ross EJ, Christie SB. Hypernatremia. Medicine (Baltimore) 1969; 48: 441-473
77. Hoorn EJ, Carlotti AP, Costa LA et al. Preventing a drop in effective plasma osmolality to minimize the likelihood of cerebral edema during treatment of children with diabetic ketoacidosis. J Pediatr 2007; 150: 467-473
78. Kang SK, Kim W, Oh MS. Pathogenesis and treatment of hypernatremia. Nephron 2002; 92(Suppl 1): 14-17
79. Lam SS, Kjellstrand C. Emergency treatment of lithium-induced diabetes insipidus with nonsteroidal anti-inflammatory drugs. Ren Fail 1997; 19: 183-188
80. Hohler T, Teuber G, Wanitschke R et al. Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus. Clin Investig 1994; 72: 769-771
81. Batlle DC, von Riotte AB, Gaviria M et al. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy. N Engl J Med 1985; 312: 408-414
82. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 1987; 10: 329-345
83. Pollock AS, Arieff AI. Abnormalities of cell volume regulation and their functional consequences. Am J Physiol 1980; 239: F195-F205
84. Blum D, Brasseur D, Kahn A et al. Safe oral rehydration of hypertonic dehydration. J Pediatr Gastroenterol Nutr 1986; 5: 232-235
85. Liamis G, Kalogirou M, Saugos V et al. Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant 2006; 21: 1564-1569